Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

This publication has 46 references indexed in Scilit:

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• The angiotensin-converting enzyme gene and its inhibition in diabetic nephropathy
  Current Opinion in Endocrinology, Diabetes and Obesity, 1996
• Factors Determining the Blood Pressure Response to Enalapril and Nifedipine in Hypertension Associated With NIDDM
  Diabetes Care, 1995
• Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
  Journal Of Hypertension, 1993
• Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.
  BMJ, 1992
• Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
  BMJ, 1991
• Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of Diabetes
  New England Journal of Medicine, 1989
• Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
  Kidney International, 1988
• Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients
  BMJ, 1988
• Plasma angiotensins and blood pressure during converting enzyme inhibition.
  Hypertension, 1987